![Friedrich Finckenstein](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Förmögenhet: 574 455 $ per 2026-05-31
Friedrich Graf Finckenstein currently works at Iovance Biotherapeutics, Inc., as Chief Medical Officer from 2019.
Dr. Finckenstein also formerly worked at F.
Hoffmann-La Roche Ltd., as Global Head-Oncology Translational Medicine.
Dr. Finckenstein received his doctorate degree from the University of Hamburg.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-06-05 | 140 111 ( 0,03 % ) | 574 455 $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2019-07-18 |
| Företag | Position | Slut |
|---|---|---|
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Företagsledare/Principal | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 3 |
|---|---|
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
University of Hamburg
 University of Hamburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Iovance Biotherapeutics, Inc.
 Iovance Biotherapeutics, Inc. BiotechnologyHealth Technology Develops biotechnological products for the treatment of cancer | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån
